The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Incidence, Time Course, and Determinants of Menstrual Bleeding After Breast Cancer Treatment: A Prospective Study
Abstract
Purpose: To assess ovarian function using the surrogate of monthly bleeding after breast cancer treatment in premenopausal women. Patients and Methods: Five hundred ninety-five US women age 20 to 45 years were accrued from January 1998 to July 2002 within 8 months of diagnosis with stages I to III breast cancer (median follow-up 45 months). Daily bleeding records were obtained prospectively, as well as extensive clinical, demographic, quality of life, and treatment data. Repeated measures logistic regression was used to assess which variables were predictive of monthly bleeding. Results: Significantly different proportions of women had monthly bleeding depending on their age (P < .001), chemotherapy program (P < .001), and time since treatment regimen. In the month after the standard course of doxorubicin and cyclophosphamide (AC), whether or not followed by paclitaxel or docetaxel, approximately 16% had monthly bleeding compared with the cyclophosphamide, methotrexate, fluorouracil (CMF) group, in which 48% bled (P < .001). Following any AC regimen, there was a slow recovery phase of about 9 months followed by a plateau, during which almost half continued monthly bleeding for the remainder of the follow-up period compared with after CMF in which there was no recovery phase and a continual decline in monthly bleeding to approximately 18% of women at study end (P < .001). Tamoxifen use decreased bleeding between months 12 and 24 after chemotherapy with 15% fewer women having bleeding. Conclusion: Using daily menstrual bleeding records, it is demonstrated that age, the specific chemotherapy regimen received, and tamoxifen use impact ovarian function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonadonna, G., Valagussa, P., Moliterni, A., Zambetti, M., & Brambilla, C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321401 · Cited by 1,049
Adjuvant Docetaxel for Node-Positive Breast Cancer
Martin, M., Pienkowski, T., Mackey, J., Pawlicki, M., Guastalla, J.-P., Weaver, C., Tomiak, E., Al-Tweigeri, T., Chap, L., Juhos, E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043681 · Cited by 954
Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
Bines, J., Oleske, D. M., & Cobleigh, M. A. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1718 · Cited by 816
Web-Based Survey of Fertility Issues in Young Women With Breast Cancer
Partridge, A. H., Gelber, S., Peppercorn, J., Sampson, E., Knudsen, K., Laufer, M., Rosenberg, R., Przypyszny, M., Rein, A., & Winer, E. P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.159 · Cited by 757
Levine, M. N., Bramwell, V. H., Pritchard, K. I., Norris, B. D., Shepherd, L. E., Abu-Zahra, H., Findlay, B., Warr, D., Bowman, D., Myles, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2651 · Cited by 617
Risk of Menopause During the First Year After Breast Cancer Diagnosis
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M., & Hood, N. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2365 · Cited by 606
SHERMAN, B. M., WEST, J. H., & KORENMAN, S. G. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-4-629 · Cited by 583
Breast Cancer in Younger Women: Reproductive and Late Health Effects of Treatment
Ganz, P. A., Greendale, G. A., Petersen, L., Kahn, B., & Bower, J. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.196 · Cited by 533
QUANTITATIVE MORPHOLOGICAL INVESTIGATIONS OF THE FOLLICULAR SYSTEM IN WOMEN
Block, E. (1952) · Cells Tissues Organs · doi:10.1159/000140595 · Cited by 517
Klein, N. A. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.7.2742 · Cited by 373
Predictors of Sexual Health in Women After a Breast Cancer Diagnosis
Ganz, P. A., Desmond, K. A., Belin, T. R., Meyerowitz, B. E., & Rowland, J. H. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2371 · Cited by 354
Jonat, W., Kaufmann, M., Sauerbrei, W., Blamey, R., Cuzick, J., Namer, M., Fogelman, I., de Haes, J. C., de Matteis, A., Stewart, A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.042 · Cited by 341
Age-related differences in the quality of life of breast carcinoma patients after treatment
Wenzel, L. B., Fairclough, D. L., Brady, M. J., Cella, D., Garrett, K. M., Kluhsman, B. C., Crane, L. A., & Marcus, A. C. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991101)86:9<1768::aid-cncr19>3.0.co;2-o · Cited by 329
Functional Impact of Breast Cancer by Age at Diagnosis
Kroenke, C. H., Rosner, B., Chen, W. Y., Kawachi, I., Colditz, G. A., & Holmes, M. D. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.173 · Cited by 304
International Breast Cancer Study Group (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg119 · Cited by 264
Pagani, O., O’Neill, A., Castiglione, M., Gelber, R. D., Goldhirsch, A., Rudenstam, C.-M., Lindtner, J., Collins, J., Crivellari, D., Coates, A., et al. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10036-3 · Cited by 227
The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients
Goldhirsch, A., Gelber, R. D., & Castiglione, M. (1990) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057718 · Cited by 196
Minton, S. E., & Münster, P. N. (2002) · Cancer Control · doi:10.1177/107327480200900603 · Cited by 153
Bath, L., Wallace, W. H., & Critchley, H. (2002) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2002.t01-1-01007.x · Cited by 130
Parulekar, W. R., Day, A. G., Ottaway, J., Shepherd, L. E., Trudeau, M., Bramwell, V. H. C., Levine, M. N., & Pritchard, K. I. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.096 · Cited by 130
Ovarian Ablation as Adjuvant Therapy for Breast Cancer
Davidson, N. E. (2001) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003464 · Cited by 44
Kobayashi, O., Murakami, H., Yoshida, T., Yoshikawa, T., Tsuburaya, A., Sairenji, M., & Notohashi, H. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.4174 · Cited by 12
Cited by
Azim, A. A., Costantini-Ferrando, M., & Oktay, K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8700 · Cited by 480
NCCN Task Force Report: Bone Health in Cancer Care
Gralow, J. R., Biermann, J. S., Farooki, A., Fornier, M. N., Gagel, R. F., Kumar, R., Litsas, G., McKay, R., Podoloff, D. A., Srinivas, S., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0215 · Cited by 412
How do chemotherapeutic agents damage the ovary?
Morgan, S., Anderson, R. A., Gourley, C., Wallace, W. H., & Spears, N. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms022 · Cited by 409
Chemotherapy-Induced Damage to Ovary: Mechanisms and Clinical Impact
Bedoschi, G., Navarro, P. A., & Oktay, K. (2016) · Future Oncology · doi:10.2217/fon-2016-0176 · Cited by 356
Amenorrhea in Premenopausal Women After Adjuvant Chemotherapy for Breast Cancer
Walshe, J. M., Denduluri, N., & Swain, S. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.2793 · Cited by 354
Metadata
- Authors
- Petrek, J. A., Naughton, M. J., Case, L. D., Paskett, E. D., Naftalis, E. Z., Singletary, S. E., & Sukumvanich, P.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-03-01
- Volume
- 24
- Issue
- 7
- Pages
- 1045-1051
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1964979154
- Cited by
- 410
- References
- 22
- FWCI
- 22.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.